share_log

HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target

Benzinga ·  Aug 7, 2023 06:26

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment